MaxCyte (MXCT) Insider Trading & Ownership → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free MXCT Stock Alerts GBX 370 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades MaxCyte (LON:MXCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.22%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)£169,092.72 Get MXCT Insider Trade Alerts Want to know when executives and insiders are buying or selling MaxCyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MXCT Insider Buying and Selling by Quarter Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. MaxCyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/26/2024John JohnstonInsiderSell5,000GBX 441£22,05011/27/2023John JohnstonInsiderSell200GBX 453£9067/26/2023John JohnstonInsiderSell118GBX 480£566.406/14/2023Doug DoerflerInsiderSell28,883GBX 504£145,570.32 (Data available from 1/1/2013 forward) MXCT Insider Trading Activity - Frequently Asked Questions Who is on MaxCyte's Insider Roster? The list of insiders at MaxCyte includes Doug Doerfler, John Johnston, and Richard Douglas. Learn more on insiders at MXCT. What percentage of MaxCyte stock is owned by insiders? 1.22% of MaxCyte stock is owned by insiders. Learn more on MXCT's insider holdings. Which MaxCyte insiders have been selling company stock? The following insiders have sold MXCT shares in the last 24 months: Doug Doerfler (£446,770.32), and John Johnston (£23,522.40). How much insider selling is happening at MaxCyte? Insiders have sold a total of 94,201 MaxCyte shares in the last 24 months for a total of £470,292.72 sold. More Insider Trading Tools from MarketBeat Related Companies: NIOX Group Insider Buying EKF Diagnostics Insider Buying Creo Medical Group Insider Buying Novacyt Insider Buying Inspiration Healthcare Group Insider Buying Advanced Oncotherapy Insider Buying Smith & Nephew Insider Buying EMIS Group Insider Buying Genus Insider Buying Oxford Nanopore Technologies Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (LON:MXCT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.